2Meyer JP,Persad R,Gllatt DA.Use of bacilli CalmetteGuerin in super ficial bladder cancer[J].Postgraduate Medical Journal,2002,78,449-454.
二级参考文献16
1Crawford ED,Wood DP,Petrylak DP,et al.Southwest Oncology Group studies in bladder cancer.Cancer,2003,97(8 Suppl),2099～2108
2Oosterlinck W.The management of superficial bladder cancer.BJU Int,2001,87,135～140
3Grob BM,Macchia RJ.Radical transurethral resection in the management of muscle-invasive bladder cancer.J Endourol,2001,15(4),419～423
4Colquhoun AJ,Jones GD,Moneef MA,et al.Improving and predicting radiosensitivity in muscle invasive bladder cancer.J Urol,2003,169(6),1983～1992
5Advanced Bladder Cancer Meta-analysis Collaboration.Neoadjuvant chemotherapy in invasive bladder cancer:a systematic review and meta-analysis.Lancet,2003,361(9373),1927～1934
6Shipley WU,Kaufman DS,Tester WJ,et al.Overview of bladder cancer trials in the Radiation Therapy Oncology Group.Cancer,2003,97(8 Suppl),2115～2119
7Meyer JP,Persad R,Gillatt DA.Use of bacille Calmette-Guerin in superficial bladder cancer.Postgraduate Medical Journal,2002,78,449～454
8Small EJ,Halabi S,Dalbagni G,et al.Overview of bladder cancer trials in the Cancer and Leukemia Group B.Cancer,2003,97(8 Suppl),2090～2098
9Herr HW,Bajorin DF,Scher HI.Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer:ten-year outcome.J Clin Oncol,1998,16,1298～1301
10Lamm DL,Blumenstein BA,Crismon JD,et al.Maintenance BCG immunotherapy for recurrent Ta,T1 and CIS TCC of the bladder:a randomized Southwest Oncology Group Study.J Urol,2000,163,1124～1129
